内皮细胞代谢在血管新生中的作用研究

血管生成是指从已有的毛细血管或毛细血管后静脉发展而形成新血管的过程。血管生成调控过程复杂,交错影响,多种基因和信号分子如血管内皮生长因子(vascular endothelial growth factor, VEGF)家族、纤维母细胞生长因子(fibroblast growth factor, FGF)家族、Notch和Wnt信号通路、转化生长因子-β(transforming growth factor-β, TGF-β)信号、血管生成素(angiotensin, Ang)和Tie信号系统等参与调控血管生成。除了遗传和分子信号外,血管生成还受到代谢机制的调节。在此,本文概述了目前对内皮细胞(endothelial cells, ECs)各种代谢途径的认识及其对生理和病理性血管生成的影响。其中,糖酵解、脂肪酸氧化和氨基酸代谢是目前最为常见的代谢途径,ECs主要依靠糖酵解产生ATP。糖酵解调节器6-磷酸果糖激酶-2/2,6-二磷酸果糖激酶3 (6-phosphofructo-2-kinase/fructose-2,6-diphosphatase 3, PFKFB3)通过调控尖端细胞(T...     

TGF-β与转录因子在肝纤维化中的相互作用

肝纤维化的形成是由于肝脏持续性损伤以及细胞外基质合成和降解失衡所引起的。转化生长因子-β(Transforming growth factor-β,TGF-β)是肝纤维化形成中的关键细胞因子,在肝纤维化发生、发展过程中起着至关重要的作用。一些与TGF-β相关的转录因子如AP1、STAT3及Foxo3a等也参与肝纤维化的调控过程。现就在肝纤维化中TGF-β与转录因子AP1、STAT3和Foxo3a的相互作用作一综述。     

肝细胞核因子4α与肝脏疾病

肝细胞核因子4α(hepatic nuclear factor 4 alpha,HNF4α)属于细胞核受体超家族成员,它在肝脏的发育、肝细胞分化成熟过程中起重要调控作用。HNF4α有阻断肝纤维化、肝硬化、肝癌的疾病进程,改善肝脏功能的作用。另外,HNF4α在肝干细胞移植方面也发挥重要作用,提高肝细胞移植的成功率。本文就HNF4α在肝细胞中的表达、作用及其相关疾病的研究进展做一综述。     

TGF—β超家族在软骨发生、发育和维持中的作用

转化生长因子β(Transforming growth factor β,TGF-β)超家族包括TGF-β和骨形态发生蛋白(Bone morphogenetic protein,BMP)两个亚家族.TGF-β超家族信号通路的配体、配体拮抗分子,受体、信号转导分子均在软骨内成骨过程中发挥各自独特的作用,参与调控软骨细胞的谱系分化、增殖、成熟、凋亡和矿化.BMP信号能起始间充质细胞向软骨细胞分化并维持软骨细胞的特性,在软骨发生过程中起主导作用;在生长板发育的过程中,BMP信号促进软骨细胞的成熟,促进成骨,而TGF-β信号抑制软骨细胞的肥大分化,维持生长板中适量的软骨细胞;TGF-β信号和BMP信号对于关节软骨的维持和修复都是不可或缺的.因此,TGF-β超家族的重要作用贯穿骨骼发育过程的始终.     

肝细胞生长因子及其临床应用研究进展

肝细胞生长因子（Hepatocyte growth factor HGF)是一种血源性促肝细胞生长因子,其作用广泛,如：促进细胞分裂,运行,对肿瘤细胞毒性作用等,并且在肝脏丙生及肝脏疾病的诊断,治疗中有重大潜力。     

TGF-β诱导CTGF表达的信号转导途径及与纤维化形成

转化生长因子-β(transforming growth factor-β,TGF-β)是一种具有多重生物学效应的细胞因子,参与了多种组织器官纤维化的形成。结缔组织生长因子(connective tissue growth factor,CTGF)是一种富含半胱氨酸的多肽,是介导TGF-β致纤维化作用的重要下游因子之一。TGF-β可通过多种信号途径诱导CTGF表达,本文就这一领域的研究进展及与纤维化形成的关系做一简要综述。     

肝细胞FGF21——新发现的机体水平衡调控因子

成纤维细胞生长因子21(fibroblast growth factor21, FGF21)由肝细胞合成并分泌入血,可穿越血脑屏障;该分子属FGF家族,由fgf21基因编码;单次跨膜蛋白β-Klotho是FGF21的辅助受体,FGF21通过β-Klotho与FGF受体(fibroblast growth factor receptors, FGFRs)结合,使β-Klotho与FGF受体发生二聚化及自磷酸化,进而激活其信号传导。     

缺失mir122抑制斑马鱼肝脏前体细胞向肝细胞分化

作为机体内最大的脏器之一, 肝脏对于机体的新陈代谢、解毒作用以及内环境的稳定有着重要的作用。FGF、BMP以及WNT信号通路及众多转录因子形成的基因调节网络精密调控着肝脏的发育, 然而小分子RNA在肝脏形成中的功能却所知甚少。近年来的研究发现, mir122在肝细胞中高表达, 对于维持肝脏的代谢功能起着至关重要的作用, 但是其在肝脏发育中的功能还不清楚。为了深入探讨mir122在斑马鱼(Danio rerio)胚胎发育中的作用, 文章首先检测了mir122在发育过程中的时空表达, 发现mir122特异表达在肝脏, 并且在肝脏前体细胞向肝细胞分化过程中表达水平显著增高。文章还通过用反义核苷酸Morpholino (MO)敲降mir122的表达, 发现敲降mir122对肝脏前体细胞的起源、肝原基的形成以及肝脏前体细胞的增殖没有明显的影响, 但是, mir122的缺失导致肝脏前体细胞不能分化为肝细胞。因此, mir122不仅参与了成体肝脏代谢功能的调节, 还在肝脏前体细胞向肝细胞分化过程中不可或缺。     

FGF8在脊椎动物早期胚胎发育中的调控作用

成纤维细胞生长因子8 (fibroblast growth factor 8,FGF8)是成纤维细胞生长因子家族的成员之一,是一种组织发育过程中的重要分泌性调控信号分子,参与脊椎动物的多种组织器官的发生与发育.早期胚胎细胞通过表达FGF8在组织和器官发育、血管发生、血细胞生成、附肢发生和伤口愈合等方面发挥着重要作用.FGF8不但可以在细胞外通过胞内信号通路,而且也可以进入细胞内部发挥生物学功能.本文就FGF8在脊椎动物神经系统、内脏器官、肢体发育及不对称发育等组织、器官发育中的调控作用予以阐述.     

肝脏发育过程中转录因子的调控

肝脏的发育经历了一系列内胚层和中胚层之间复杂的相互作用,其中转录因子扮演着重要角色。肝脏发育主要可分为两个阶段,首先是前肠内胚层感受心脏中胚层的信号而建立响应态(competence),肝向特化基因逐渐表达并形成新生肝芽。此阶段受到转录调控网络的控制,其中FoxA家族,锌指结构转录因子GATA4/6,同源结构域因子Hhex、Onecut1、Onecut2和Prox1发挥了重要的作用。其次是肝脏内细胞群体如肝细胞和胆管细胞的分化成熟阶段。这个过程的完成主要受肝富集转录因子HNF1α、HNF4、HNF6和C/EBPα的调控。本文概述了肝脏发育中复杂的转录调控网络及其发挥的作用。     

On the compartmentalization of catalase,fatty acyl-CoA oxidase and urate oxidase in mammalian livers,and the influence of clofibrate treatment on this microlocalization

The compartmentalization of catalase, fatty acyl-CoA oxidase and urate oxidase was examined in the livers of mice, rats and guinea pigs, using the technique of digitonin extraction in order to avoid the trauma associated with centrifugation procedures. The results are interpreted as indicating that an appreciable proportion of catalase activity occurs in the cytoplasmic compartment of these cells. Following treatment of the animals with clofibrate, the specific activity in both peroxisomal and cytoplasmic compartments was increased, with a higher proportion of cytoplasmic catalase being evident in mice. The results for catalase were compared with those for fatty acyl-CoA oxidase and urate oxidase both of which were indicated as showing a closer association with the peroxisomal compartment than was the case for catalase. These data have been discussed in relation to their significance on present understanding of peroxisomal structure and function.     

自噬在肝再生中的作用

自噬是存在于真核细胞内的一种溶酶体依赖性的降解途径,在肝脏生理和病理过程中发挥着重要作用。肝脏具有强大的再生能力,在受到急、慢性损伤时,残肝细胞将会被激活进入细胞周期进行细胞增殖,以补偿丢失的肝组织和恢复肝功能。文章阐述了各种类型损伤之后的肝再生与自噬的关系。在物理性、酒精、食源性等因素引起的肝损伤中,肝脏通过启动自噬来促进肝再生;在化学性损伤的肝再生模型中,自噬在其中的作用仍然有争议;在病毒感染之后的肝再生中,一些嗜肝病毒（如丙肝病毒和乙肝病毒等）反而利用自噬来促进病毒颗粒复制,抑制肝再生。对自噬和肝再生机制的研究,将有助于进一步阐明再生过程,为治疗肝脏疾病提供新方法。     

Is the ATP — dependent protection of lysosomes against osmotic lysis a function of the lysosomal proton pump

Summary Rat liver lysosomes have been used to characterize further the effects of ATP on lysosomal stability during incubation at 37°C at hypo-osmolarity. As previously reported, when the osmotically-supporting solute is the salt of a strong base (K⁺), ATP protects against lysis during incubation. However, if the osmotically-supporting solute is the salt of a weak base, e.g. Tris HCl or NH₄Cl, ATP actually promotes lysis during incubation. Thus, ATP can exert destabilizing as well as protective effects on lysosomes. The destabilizing effect is eliminated by protonophores. The protective effect in the presence of potassium salts is not eliminated by protonophores. Moreover, when incubation is in the presence of a salt of a weak base, protonophores actually cause an ATP-dependent protective effect to be established. The destabilizing effect occurs at 37°C, but not at 0°C. The Mg^–+-dependence of the destabilizing effect was found to be similar to that found earlier for the ATP-dependent protective effect, insofar as only 1 mM MgCl₂ in the presence of 1 mM EDTA is sufficient for nearly maximal stimulation of both effects. The destabilizing effect may result from a H^– ion gradient across the lysosomal membrane which is maintained by the lysosomal ATP-dependent proton pump. The protective effect, on the other hand, does not depend on such a gradient being maintained; on the contrary, protonophores appear to act as enablers of the protective effect. The question that remains to be answered is: does the protective effect derive in some way from the same ATP-driven mechanism which constitutes the proton pump? Some possible answers to this question are considered.Abbreviations Mops 2-(N-morpholine)-propanesulfonic acid - CCCP Carbonyl cyanide m-chlorophenylhydrazone - DNP 2,4-Dinitrophenol - EDTA Ethylenediaminetetracetic acid     

Isolated hepatocytes in a bioartificial liver: A single group view and experience

Despite recent advances in medical supportive therapy, patients with severe fulminant hepatic failure (FHF) have mortality rate approaching 90%. Investigators have attempted to improve survival by using various extracorporeal liver support systems loaded with sorbents and liver tissue preparations. None of them succeeded in gaining clinical acceptance and orthotopic liver transplantation (OLT) remains a primary therapeutic option for patients with FHF. In this study, authors discuss the systems which utilize isolated hepatocytes. Most of these devices were tested in vitro and in animals with chemically and surgically induced liver failure. In some studies, signficant levels of detoxification and liver functions were achieved. The authors describe their own hepatocyte-based artificial liver (BAL). It is based on plasma perfusion through a hollow-fiber module seeded with matrix-anchored porcine hepatocytes. The BAL was used 14 times to treat 9 patients with acute liver failure. On 10 occasions, a charcoal column was included in the plasma circuit. Each treatment lasted 7 +/- 1 h. All procedures were tolerated well and 8 patients (including 6 patients with FHF) underwent OLT. Five patients with increased intracranial pressure (ICP) and evidence of decerebration had normalization of ICP and enjoyed full neurologic recovery after OLT. Laboratory data showed evidence for bilirubin conjugation, decrease in blood ammonia, maintenance of low lactic acid levels, and increase in the ration between the branched chain and aromatic amino acids. No allergic reactions to xenogeneic hepatocytes were observed. The authors conclude that BAL treatment with porcine hepatocytes appears to be safe and can help maintain patients alive and neurologically intact until a liver becomes available for transplantation. (c) 1994 John Wiley & Sons, Inc.     

Hippo信号通路与肝脏稳态调控及疾病发生

肝脏是人体最重要的器官之一,乙肝等病毒性与酒精等非病毒性因素诱发的肝损伤引起肝脏功能衰竭、再生重塑障碍、肝癌等疾病是我国重大社会健康问题,因此,研究肝脏稳态的调控机制对肝病的预防和临床治疗至关重要。Hippo信号通路参与了哺乳动物多种细胞和器官的稳态调控。最近研究表明,Hippo信号通路在肝脏发育、肝细胞命运决定、肝脏再生和癌症发生发展等过程中都发挥了非常重要的作用。因此,Hippo信号通路可成为肝脏相关疾病的治疗提供了新的靶点。本文综述了Hippo信号通路与肝脏稳态调控的相关研究及最新进展,以期为研究肝脏发育和肝脏相关疾病的治疗提供新的思路和策略。     

肝星型细胞分离方法和功能研究进展

肝星型细胞(Hepatic stellate cells,HSCs),又叫储脂细胞(Fat-storing cells,FSCs)或脂肪细胞(lipocytes),是肝脏固有的非实质细胞类型之一,存在于狄氏腔内,以脂滴的形式储存人体维生素A总量的50%–80%。原代HSCs分离方法,目前主要集中于密度梯度离心法结合离心淘洗、HSCs高侧向角的流式分选法、紫外激发的自发荧光或特异性抗体标记的流式细胞术等,将为HSCs生理和病理研究提供坚实的基础。近年来,HSCs的研究蓬勃发展,合作领域不断拓宽。生理状态下,HSCs处于静息状态,合成细胞外基质(Extracellular matrix,ECM)并维持其稳态,同时广泛摄取和储存维生素A,并具有调节肝细胞再生的功能;而病理状态下,HSCs在肝损伤和持续性刺激条件下被激活,增殖活性明显增强,脂滴减少或消失,ECM合成也明显增加,具有收缩性,同时分泌多种促炎因子和粘附分子,并向肌成纤维细胞转变,表明HSCs的活化是肝纤维化发生发展过程中的关键环节之一。有关HSCs的分离和功能研究一直是肝脏细胞学和肝脏病理学研究的热点之一。文中我们将系统总结和探讨HSCs的分离方法和改进策略,及其功能研究进展和具有潜在价值的研究方向。     

不典型原发性肝癌的CT特征分析

目的分析不典型原发性肝癌(PLC)CT动态强化方式。方法回顾性分析临床及病理证实的29例原发性肝癌中4例多期动态增强CT不典型表现。结果 29例病灶平扫均呈低密度,22例肝细胞癌(hepatocellular carcinoma,HCC)增强扫描呈典型改变(动脉期强化,门脉期及平衡期造影剂廓出或门脉期强化,平衡期造影剂廓出)。1例HCC呈渐进性强化呈等密度,再延时扫描出现低密度环;1例肿块出现坏死、囊变并出血,周边持续明显强化并见增粗血管;2例胆管细胞癌(cholangiocarcinoma,CC)呈分叶或不规则,渐进性强化不达等密度,无胆管扩张。结论少部分原发性肝癌因病灶内组织成分不同致影像表现不典型,需结合多相期表现进行分析,必要时应行穿刺取活检,以减少误诊。     

Preclinical characterization of alginate‐poly‐L‐lysine encapsulated HepaRG for extracorporeal liver supply

We recently demonstrated that HepaRG cells encapsulated into 1.5% alginate beads are capable of self‐assembling into spheroids. They adequately differentiate into hepatocyte‐like cells, with hepatic features observed at Day 14 post‐encapsulation required for external bioartificial liver applications. Preliminary investigations performed within a bioreactor under shear stress conditions and using a culture medium mimicking acute liver failure (ALF) highlighted the need to reinforce beads with a polymer coating. We demonstrated in a first step that a poly‐l ‐lysine coating improved the mechanical stability, without altering the metabolic activities necessary for bioartificial liver applications (such as ammonia and lactate elimination). In a second step, we tested the optimized biomass in a newly designed perfused dynamic bioreactor, in the presence of the medium model for pathological plasma for 6 h. Performances of the biomass were enhanced as compared to the steady configuration, demonstrating its efficacy in decreasing the typical toxins of ALF. This type of bioreactor is easy to scale up as it relies on the number of micro‐encapsulated cells, and could provide an adequate hepatic biomass for liver supply. Its design allows it to be integrated into a hybrid artificial/bioartificial liver setup for further clinical studies regarding its impact on ALF animal models.     

Pluripotent plasticity of stem cells and liver repopulation

Different types of stem cells have a role in liver regeneration or fibrous repair during and after several liver diseases. Otherwise, the origin of hepatic and/or extra‐hepatic stem cells in reactive liver repopulation is under controversy. The ability of the human body to self‐repair and replace the cells and tissues of some organs is often evident. It has been estimated that complete renewal of liver tissue takes place in about a year. Replacement of lost liver tissues is accomplished by proliferation of mature hepatocytes, hepatic oval stem cells differentiation, and sinusoidal cells as support. Hepatic oval cells display a distinct phenotype and have been shown to be a bipotential progenitor of two types of epithelial cells found in the liver, hepatocytes, and bile ductular cells. In gastroenterology and hepatology, the first attempts to translate stem cell basic research into novel therapeutic strategies have been made for the treatment of several disorders, such as inflammatory bowel diseases, diabetes mellitus, celiachy, and acute or chronic hepatopaties. In the future, pluripotent plasticity of stem cells will open a variety of clinical application strategies for the treatment of tissue injuries, degenerated organs. The promise of liver stem cells lie in their potential to provide a continuous and readily available source of liver cells that can be used for gene therapy, cell transplant, bio‐artificial liver‐assisted devices, drug toxicology testing, and use as an in vitro model to understand the developmental biology of the liver. Copyright © 2010 John Wiley & Sons, Ltd.     

Percutaneous liver core biopsy in rats: an alternative to minilaparotomy

Sampling of rat hepatic tissue for histomorphological analysis is usually performed in two different ways: either by killing the animals or by minilaparotomy.In this study we describe a percutaneous core biopsy technique which has been used on day 7, 14 and 21 after allogeneic rat liver transplantation (DA → LEW) in order to examine grafts for rejection in different treatment groups. Fifty-two liver biopsies were performed in 24 animals using a 16-gauge intravenous cannula. Forty-five provided usable specimens which were sufficient for both light or electron microscopy and immunohistochemical analyses to determine the degree of graft rejection. In 7 cases (13.5%) sampling was unsuccessful, especially on day 21 after transplantation, as the plastic cannula could not penetrate the hardened tissue. In 3 animals (5.8%) puncture was immediately followed by death due to perforation of the diaphragm or ether intoxication.In conclusion, this technique is a reliable method for providing ample tissue samples from the rat liver with a low risk of complications.